NCT05907603 Research Development(RD)13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7(CD7)+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML) Status COMPLETED Phase EARLY_PHASE1
NCT05902845 RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL Status COMPLETED Phase EARLY_PHASE1
NCT05895994 Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies Status COMPLETED Phase EARLY_PHASE1
NCT05827835 CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases Status RECRUITING Phase PHASE1/PHASE2
NCT05755854 Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors Status RECRUITING Phase PHASE1
NCT05660265 A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years Status TERMINATED Phase PHASE1
NCT05641324 A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2) Status TERMINATED Phase PHASE1
NCT05587881 Clinical Study on the Impact of Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell Transplantation Status WITHDRAWN Phase N/A
NCT05487794 Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men with Erythrocytosis Status COMPLETED Phase NA
NCT05477563 Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease Status RECRUITING Phase PHASE3
NCT05443321 Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes Status ENROLLING_BY_INVITATION Phase NA
NCT05378139 Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization Status RECRUITING Phase N/A
NCT05356195 Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05351866 Digital Therapeutic for Adolescent Depressive Symptoms in Hematology, Oncology, and Weight Management Status TERMINATED Phase NA